- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06730074
A Novel Robotic System for Motor-cognitive Exercise for Patients With Parkinson's Disease (PD)
Study Overview
Status
Conditions
Detailed Description
Participants & Protocol:
Recruitment: Advertising ads in movement disorders units in hospitals and medical centers in the south, as well as through the help of the Parkinson's Association.
The study will be conducted with 15 PD patients, aged 50-75, at the Adi Negev Clinic. Each patient will use the robotic system five times, with each session lasting 30 minutes. The intervention plan incorporates principles of effective rehabilitation practice, including repeated practice, goal-oriented practice, variable difficulty, rhythmic cueing, and social interaction. Before the research begins, participants will sign an informed consent form.
Baseline and Pre-Post Tests:
Assessments including the MoCA, demographic data, clinical data, Color Trails Test (CTT), motor UPDRS, Box & Blocks Test, and Cognitive Reserve Index Questionnaire (CRIq) will be collected before the first session by an occupational or physical therapist. After the fifth session, post-intervention assessments will include motor UPDRS, Box & Blocks Test, CTT, System Usability Scale (SUS), Intrinsic Motivation Inventory (IMI), and a satisfaction questionnaire.
Hypothesis:
It is hypothesized that motor and cognitive training using the robots will improve the patients' clinical symptoms, as evidenced by pre-post test results.
Novelty & Impact:
This is the first socially assistive robotic platform developed specifically for people with PD. If successful, this platform could be incorporated into the clinical toolbox at Adi Negev and other centres. Additionally, this study will be the first to use the Cognitive Reserve Index Questionnaire (CRIq) in Hebrew for people with PD. The potential impact of this project is twofold: testing a new rehabilitation tool and a screening tool for PD patients.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Dori Katz, Medical Doctor
- Phone Number: +972 52 268 9046
- Email: dorik@adi-il.org
Study Contact Backup
- Name: Ilanit Baum Cohen, Msc. OT
- Phone Number: +972 52 8807 503
- Email: ilanit.nit@gmail.com
Study Locations
-
-
South
-
Ofakim, South, Israel
- Recruiting
- Adi Negev
-
Contact:
- Dori Katz, DR
- Phone Number: +972522689046
- Email: ilanit.nit@gmail.com
-
Contact:
- Neta Kislev, OT
- Phone Number: +972547918662
- Email: netakislev.ot@gmail.com
-
Sub-Investigator:
- Ilanit Baum-Cohen, OT
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Signing the informed consent form
- Men and women in ages 50-75
- Hebrew speakers
- Have Idiopathic Parkinson's disease
- Hoehn and Yahr 3 and below
- Moca test 23 and above
Exclusion Criteria:
- Patients with Parkinson's plus syndromes
- PD patients who suffer from unrelated neurological symptoms.
- Orthopedic problems of the upper limb
- Recent surgery conducted on the upper limb
- Uncorrected vision problems
- Uncorrected severe hearing loss
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Gamified rehabilitation system involving robot for individuals with Parkinson's
We will run a robotic exercise game with 15 PD patients who will use the system in a sitting position.
Each patient will use the system 5 times, each time for 30 min.
Principles of effective rehabilitation practice such as repetitive practice, goal-oriented practice, variable difficulty, rhythmic cueing, and social interaction are implemented in our design
|
This is the first socially assistive robotic platform developed specifically for people with PD.
If successful, this platform could be incorporated into the clinical toolbox at Adi Negev and other centres.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
level of engagement
Time Frame: 2 Mon
|
We will ask participants to rate their perceived level of engagement with the platform.
|
2 Mon
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
improvement in UPDRS
Time Frame: 4 Mon
|
We will perform post-intervention assessments which include motor UPDRS (Unified Parkinson Disease Rating Scale)
|
4 Mon
|
|
improvement in fine motor coordination
Time Frame: 4 Mon
|
We will perform post-intervention assessments which include Box and Blocks Test for fine motor coordination.
|
4 Mon
|
|
improvement in CTT (Color Trail Test)
Time Frame: 4 Mon
|
We will perform post-intervention assessments which include CTT (Color Trail Test) for executive functions.
|
4 Mon
|
|
Testing the usability of use of the system
Time Frame: 4 Mon
|
We will perform post-intervention assessments which include System Usability Scale (SUS).
|
4 Mon
|
|
Measuring the motivation to use the system
Time Frame: 4 Mon
|
We will perform post-intervention assessments which include the Intrinsic Motivation Inventory (IMI).
|
4 Mon
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0005-NGV-24
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease, Idiopathic
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
Hacettepe UniversityCompletedIdiopathic Parkinson DiseaseTurkey
-
Chase Therapeutics CorporationActive, not recruitingIdiopathic Parkinson DiseaseUnited States
-
PfizerCompletedIdiopathic Parkinson DiseaseUnited States, Belgium
-
UCB PharmaCompletedIdiopathic Parkinson DiseaseCzechia, Denmark, Germany, Greece, Italy, Mexico, Romania, Slovakia, Spain, Switzerland
-
Kenai TherapeuticsCalifornia Institute for Regenerative Medicine (CIRM)RecruitingParkinson's Disease | Idiopathic Parkinson´s DiseaseUnited States
-
NeuraLightCompletedIdiopathic Parkinson DiseaseIsrael
Clinical Trials on Using a gamified rehabilitation system in a sitting position involving robots and music for the benefit of individuals with Parkinson's disease (PD)
-
Assistance Publique - Hôpitaux de ParisRecruiting